Diagnosis, Screening, and Early Detection of Leukemia
Leukemia is a cancer that begins in the blood-forming tissue of the bone marrow, and identifying it early is central to effective treatment. This article looks at how leukemia is diagnosed: how initial screening tests are used, what confirms a diagnosis, and how the evaluation process differs between adults and children.
Key Takeaways
- Because early leukemia symptoms are often vague, most cases come to light through diagnostic blood testing rather than through symptom recognition alone.
- A complete blood count with differential is usually the first test ordered when leukemia is suspected, and it can show abnormal white cell counts, anemia, or a low platelet count.
- A bone marrow aspiration and biopsy remains the standard test for confirming leukemia, typically followed by cytogenetic, molecular, and flow cytometry testing to characterize the disease further.
- There is no organized screening program for the general population; evaluation is triggered by symptoms or by known risk factors such as certain genetic conditions or significant chemical or radiation exposure.
- Diagnostic steps are broadly similar for adults and children, but the mix of leukemia types differs by age, which shapes how quickly and in what order testing proceeds.
Recognizing Early Signs of Leukemia
Leukemia often produces symptoms that resemble common, non-cancerous conditions, which is one reason it is frequently identified only once diagnostic testing is already underway. A full description of leukemia’s signs and symptoms is covered on our dedicated symptoms page; the focus here is on how those symptoms feed into the screening and diagnostic process described below.
Common Early Symptoms
Fatigue, easy bruising, recurrent infections, and unexplained weight loss are among the changes that most often lead a clinician to order an initial blood test. Because none of these signs is specific to leukemia, they are interpreted together with blood count results rather than used on their own to reach a diagnosis.
Age-Specific Warning Signs
How these signs present can differ somewhat between children and adults, which is part of why the diagnostic pathways described later in this article are tailored by age group rather than following one fixed protocol.
Leukemia Screening Methods Explained
There is no evidence-based, population-wide screening program for leukemia in the way there is for some other cancers. Testing is generally prompted by symptoms or by recognized risk factors rather than performed routinely in people without symptoms.
Initial Blood Work
The primary tool for initial evaluation is a complete blood count with differential, which measures red blood cells, white blood cells, and platelets, and breaks down the types of white blood cells present. Results that may point toward leukemia include unusually high or low white blood cell counts, immature white blood cells known as blasts, a low red blood cell count (anemia), or a low platelet count (thrombocytopenia). If these results are abnormal, a peripheral blood smear is often the next step, in which a pathologist examines the blood cells directly under a microscope.
Who Should Be Screened?
Routine leukemia screening is not recommended for people without symptoms. Evaluation is typically started when someone has persistent, unexplained symptoms or a known risk factor. These can include certain inherited conditions, such as Down syndrome, which raises a child’s risk of developing leukemia; a history of significant radiation exposure; or long-term exposure to certain chemicals, such as benzene, which has been linked to a higher risk of leukemia in adults. Most people with these risk factors never develop leukemia, and the decision to test is made individually with a healthcare professional.
Comprehensive Leukemia Diagnosis Methods
When initial screening results suggest leukemia, more definitive testing follows to confirm the diagnosis and gather the information needed for treatment planning.
Confirmatory Bone Marrow Tests
A bone marrow aspiration and biopsy is the standard method for confirming a leukemia diagnosis. These related procedures remove a small sample of liquid marrow and a small piece of bone, usually from the hip bone, and send the samples to a laboratory for review by a pathologist. The pathologist looks at the percentage of abnormal blast cells present, the overall cellularity of the marrow, and whether its normal structure has been disrupted. Together, these findings confirm whether leukemia is present and whether it behaves more like an acute or a chronic disease, which guides the choice of further testing.
Molecular and Genetic Analysis
Beyond the microscopic exam, molecular and genetic tests add detail about the leukemia cells that can influence prognosis and treatment choices. Cytogenetic testing examines the chromosomes inside leukemia cells for structural changes, such as rearranged chromosome segments. Fluorescence in situ hybridization (FISH) is a more sensitive technique that can pick up some genetic changes too small to see with standard cytogenetics, while polymerase chain reaction (PCR) testing can detect very small amounts of specific genetic mutations. Flow cytometry identifies proteins on the surface of leukemia cells, helping classify which type of blood cell the leukemia developed from. Together, these tests give a more precise picture of the disease than blood counts or marrow appearance alone.
Diagnosing Leukemia in Adults and Children
The core diagnostic tools are the same across age groups, but the overall pathway can differ, since the mix of leukemia types and the patient factors clinicians weigh are not identical in adults and children.
Adult Leukemia Diagnostic Pathways
In adults, the diagnostic pathway typically follows the order described above: initial blood work, then a bone marrow aspiration and biopsy, followed by molecular and genetic testing to characterize the disease. Chronic forms of leukemia tend to have a more gradual symptom onset than acute forms, and adult work-ups often also take other existing health conditions into account, since these can influence which treatments are appropriate.
Unique Aspects of Childhood Diagnosis
Among cancers that occur in childhood, ALL tops the list in frequency, and leukemias overall tend to peak in the 1-to-4-year-old age band more than in older kids. Because acute leukemias in children can progress quickly, the diagnostic work-up is often moved through promptly once it begins. Supporting the child and family through this process is an important part of pediatric care, and is covered in more detail elsewhere on this site.
Frequently Asked Questions
How quickly does leukemia progress?
This depends heavily on the leukemia type. Acute leukemias can progress within weeks to months and usually require prompt treatment, while chronic leukemias typically progress slowly over years, and some patients with a chronic form may be monitored with watchful waiting rather than treated right away. An accurate diagnosis is what determines which pattern applies to a given patient.
Can leukemia be completely cured?
Many types of leukemia, including many childhood cases of acute lymphoblastic leukemia, can reach long-term remission with intensive treatment such as chemotherapy or stem cell transplantation, and for some patients this amounts to a cure. Detailed outcome statistics are covered in our survival rate and prognosis overview for leukemia; what matters for diagnosis is that outcomes vary by leukemia subtype, age, overall health, and how the disease responds to treatment, so an accurate diagnosis is the necessary first step toward the most effective treatment plan.
Are there any lifestyle factors that increase the risk of leukemia?
The exact cause of most leukemias is unknown, but some risk factors are well established. These include exposure to high doses of radiation, long-term exposure to certain chemicals such as benzene, and specific genetic conditions such as Down syndrome. Cigarette smoking is a recognized cause of acute myeloid leukemia specifically. Having one or more of these factors does not mean leukemia is inevitable — most people with them never develop it — and conversely, plenty of people who are diagnosed cannot point to any known risk factor behind their disease. Because of this, routine screening is not recommended for people without symptoms or known risk factors.
Sources
